4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-143056
Chief Legal Officer sold 1,841 shares at $24.66 ($45,399)
- Chief Legal Officer acquired 1,841 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ali-Jackson Kamil · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-09-28 | Exercise or conversion : show line 1 in the form | +1,841 | $0.72 | $1,326 | 77,798 | D |
| 2016-09-28 | Sale : show line 2 in the form | −1,841 | $24.66 | $45,399 | 75,957 | D |
| Open-market sales · 1,841 sh · avg $24.66 · $45,399 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-09-26 | Exercise or conversion : show line 3 in the form Employee StockOption (right to buy) | −1,841 | 2,176 | D |
Loading xslF345X03/doc4.xml…